WinstonWınston
Back
SynBiotic SE logo

SynBiotic SE

SBX.DE
34
Drug Manufacturers - Specialty & Generic · Healthcare
Exchange
Deutsche Börse
Winston Score
34
Winston is serious
Below-average fundamentals — multiple weak pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2024
How the score breaks down
Quality
Mixed
Growth
Weak
Cash Flow
Weak
Stability
Good
Valuation
Data not available

Winston Score History

The full picture

SynBiotic SE is a German company that focuses on cannabis-based health and wellness products. It sells medicinal cannabis, CBD supplements, and related natural health products to pharmacies, medical patients, and wellness consumers. The company operates in the fast-growing but heavily regulated European cannabis market, primarily in Germany.

SynBiotic makes money by selling its products directly and through pharmacy distribution channels. It is a small-cap company based in Germany, and its business has grown partly through acquiring smaller cannabis and natural health brands. However, the deeply negative operating margin shows the company is spending far more than it earns, which is a serious concern. The key growth driver is Germany's ongoing cannabis liberalization — Germany loosened its cannabis laws in 2024, which could expand the legal market — but the main risk is that SynBiotic must reach profitability before it runs out of financial runway.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

YoY Growth Rate

Revenue data limited

EPS Growth

YoY Growth Rate

EPS data limited

Insider Activity

45.8%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

€42M cash & investments

Company generates more cash than it spends — no dilution risk from fundraising

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
40.9%
Healthy — 40.9% gross margin
Profit after running costs
Operating Margin
15.1%
Healthy — 15.1% operating margin
Return on the money invested
ROCE
0.0%
Weak — 0.0% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
N/A
Data not available
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
2/4 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
0.0%
Thin free cash flow (0.0%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.05
Conservative — low debt load (0.05)
Covers its interest
Interest Cover
0.03x
Dangerous — barely covers interest (0.0x)

Interest coverage below 1. Their profits don't cover the interest bill.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
no trend
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial